Post navigation Dianthus Therapeutics announces proposed $400 million public share offeringCell and Gene Therapy Manufacturing Market to Reach USD 146.2 Billion by 2032 Amid Rising Demand for Personalized Therapies, Viral Vector Capacity, and Automated Bioprocessing – Credence Research